Roivant Sciences Income Statement (2020-2025) | ROIV

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 1.58M1.32M5.75M7.74M13.99M24.34M4.32M12.53M17.05M21.62M3.65M15.56M7.99M4.47M9.02M2.17M1.57M
Gross Profit 1.40M0.61M5.07M6.99M7.61M22.96M2.59M8.89M13.47M17.41M3.42M15.37M7.78M4.24M8.76M2.02M1.46M
Operating items
Research & Development 58.73M97.41M202.26M78.52M132.10M137.34M135.83M132.00M125.53M125.13M114.79M108.15M120.51M143.07M141.59M152.92M164.57M
Selling, General & Administrative 57.12M59.74M61.88M82.75M437.78M115.53M149.07M157.66M168.26M156.19M88.58M128.17M99.89M202.88M141.54M134.02M143.12M
Other Operating Expenses 0.18M0.71M0.68M0.85M66.47M17.49M1.73M3.64M101.33M16.71M14.17M0.20M0.21M0.23M0.26M0.15M0.11M
Operating Expenses 116.03M157.86M264.82M162.12M698.42M270.36M286.63M293.30M395.13M298.04M217.54M236.52M220.61M346.19M283.40M287.09M307.80M
Operating Income -114.45M-156.54M-259.07M-154.39M-684.43M-246.02M-282.31M-280.77M-378.08M-276.41M-213.89M5,127.45M-102.23M-341.71M-274.38M-284.92M-306.23M
EBIT -114.45M-156.54M-259.07M-154.39M-684.43M-246.02M-282.31M-280.77M-378.08M-276.41M-213.89M5,127.45M-102.23M-341.71M-274.38M-284.92M-306.23M
Non-operating items
Non Operating Investment Income 41.15M84.30M-18.23M-8.62M443.75M-38.04M-24.55M-54.68M25.95M-7.56M-45.85M-10.47M15.23M48.38M-21.31M-19.12M128.50M
Interest & Investment Income 0.07M0.07M1.98M5.67M10.25M16.71M14.30M31.95M72.13M69.77M61.85M48.32M45.34M
Other Non Operating Income -2.84M0.76M5.79M0.13M-3.69M1.03M-1.08M-5.95M18.09M4.59M-1.53M2.11M-3.61M-1.45M-2.82M-11.21M-5.69M
Non Operating Income -2.84M0.76M5.79M0.13M-3.69M2.46M-1.08M-5.95M18.09M4.59M-1.53M2.11M-3.61M-1.45M-2.82M-11.21M-5.69M
Net income details
EBT -6.76M-52.79M-275.82M-100.98M-225.24M-306.05M-349.79M-313.76M-382.08M-326.09M-241.41M5,153.55M-19.64M-224.38M-234.51M-269.26M-159.04M
Tax Provisions 1.22M0.71M-0.22M0.09M0.40M0.04M4.00M2.17M2.82M1.75M3.24M22.36M11.96M12.46M-25.57M4.65M7.00M
Profit After Tax -8.00M-53.50M-275.60M-101.10M-225.64M-306.08M-353.80M-315.92M-384.90M-327.85M-331.12M5,154.47M95.30M-279.92M-208.94M-273.91M-166.04M
Income from Non-Controlling Interests -4.73M-18.10M-14.57M-18.89M-17.16M-21.55M-21.98M-24.33M-32.88M-36.03M-26.79M-23.52M-37.81M-49.74M-51.31M-50.56M-52.52M
Income from Continuing Operations -7.98M-53.50M-275.60M-101.08M-225.64M-306.08M-353.78M-315.92M-384.90M-327.85M-244.64M5,131.18M-31.60M-236.84M-208.94M-273.91M-166.04M
Consolidated Net Income -7.98M-53.50M-275.60M-101.08M-225.64M-306.08M-353.78M-315.92M-384.90M-327.85M-82.62M-58.52M89.09M-43.08M327.02M-273.91M-166.04M
Income towards Parent Company -7.98M-53.50M-275.60M-101.08M-225.64M-306.08M-353.78M-315.92M-384.90M-327.85M-82.62M-58.52M89.09M-43.08M327.02M-273.91M-166.04M
Net Income towards Common Stockholders -7.98M-53.50M-275.60M-101.08M-225.64M-306.08M-353.78M-315.92M-384.90M-327.85M-82.62M-58.52M89.09M-43.08M327.02M-273.91M-166.04M
Additional items
EPS (Basic) -0.02-0.06-0.41-0.13-0.32-0.41-0.48-0.42-0.49-0.38-0.406.440.13-0.310.23-0.33-0.17
EPS (Weighted Average and Diluted) -0.13-0.32-0.41-0.48-0.42-0.49-0.38-0.406.100.12-0.310.23-0.33-0.17
Shares Outstanding (Weighted Average) 62.50M51.34M51.34M684.79M684.79M684.79M692.07M700.77M703.63M725.42M758.43M766.81M771.74M803.92M805.85M738.72M739.52M727.95M713.55M679.81M682.88M
Shares Outstanding (Diluted Average) 649.86M650.23M686.59M669.75M695.88M699.89M713.32M712.79M759.27M770.23M844.46M831.05M781.63M735.64M731.32M725.40M680.29M680.95M
EBITDA -114.45M-156.54M-259.07M-154.39M-684.43M-246.02M-282.31M-280.77M-378.08M-276.41M-213.89M5,127.45M-102.23M-341.71M-274.38M-284.92M-306.23M
Interest Expenses 2.61M8.34M8.45M8.91M9.25M9.44M13.40M
Shares Outstanding 628.78M628.78M630.17M651.58M651.58M684.79M692.01M694.98M701.17M704.39M726.80M760.14M767.14M800.79M804.89M806.68M739.05M733.33M719.63M695.94M682.23M
Tax Rate 0.080.4310.90